Skip to main content
Stem Cell Reports logoLink to Stem Cell Reports
. 2020 May 12;14(5):989–990. doi: 10.1016/j.stemcr.2020.03.025

Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells

Yangling Li, Miao Xian, Bo Yang, Meidan Ying , Qiaojun He ∗∗
PMCID: PMC7220985  PMID: 32402269

Main Text

(Stem Cell Reports 8, 1617–1629; June 6, 2017)

In the original version of this article, there were unintended errors in Figure 2C and Figure 6G. Specifically, in Figure 2C, pictures of scratch assay of MDOS20 cells are the same for control group and ADR group treated for 0 h. In Figure 6G, images of transwell migration assay are the same for Simva group and Simva+ADR group. The correct pictures of scratch assay for ADR group in Figure 2C and transwell migration assay for Simva group in Figure 6G now appear below. The authors sincerely regret these unintentional duplications. These corrections do not alter the main conclusions drawn from this study.

graphic file with name gr2.jpg

Figure 2. ADR Induces Metastasis of Osteosarcoma Cells (corrected)

graphic file with name gr6.jpg

Figure 6. Statins Inhibit KLF4 Expression and Osteosarcoma Cancer Stemness Traits In Vitro (corrected)

Contributor Information

Meidan Ying, Email: mying@zju.edu.cn.

Qiaojun He, Email: qiaojunhe@zju.edu.cn.


Articles from Stem Cell Reports are provided here courtesy of Elsevier

RESOURCES